CAR T-Cell Therapy Market Forecasts Growth from $7.24B (2026) to $13.78B by 2031, Profiling Bristol-Myers Squibb, Gilead Sciences, Novartis & J&J

Positive

AI Analysis

Summary

Market research forecasts the CAR T-cell therapy market will grow from $7.24B in 2026 to $13.78B by 2031, with major players including Bristol-Myers Squibb, Gilead Sciences, Novartis, and J&J profiled in the analysis.

Financial Highlights

Guidance

CAR T-cell therapy market forecasted to grow from $7.24B (2026) to $13.78B (2031)

Importance:2/10

Sentiment:

0.50

CAR T-cell therapymarket forecastoncologyimmunotherapy

Related Companies

$BMY $GILD $NVS $JNJ

Read the original article

Published by yahoo_finance on September 30, 2026 8:47 AM

Read Original